公开(公告)号：US20140307233A1

公开(公告)日：2014-10-16

申请号：US14105109

申请日：2013-12-12

Applicant: Yen-Po Chang ,  Hui-Ping Chen

Inventor： Yen-Po Chang ,  Hui-Ping Chen

IPC: G03B21/28

CPC classification number: G03B21/28

Abstract: A projection apparatus includes a casing with an opening, a light-emitting unit in the casing and emitting a first projection beam, and a reflective component in the casing and on a transmission path of the first projection beam. The first projection beam reflected by the reflective component becomes a second projection beam projected out via the opening along a projection direction. The light-emitting unit includes a projection lens with an optical axis between a center of the reflective component and the opening of the casing.

Abstract translation: 投影装置包括具有开口的壳体，壳体中的发光单元，并且发射第一投影光束，以及在壳体中的反射部件和第一投影光束的传输路径上。 由反射部件反射的第一投影光束成为沿着投影方向经由开口突出的第二投影光束。 发光单元包括具有在反射部件的中心和壳体的开口之间的光轴的投影透镜。

公开(公告)号：US20110165186A1

公开(公告)日：2011-07-07

申请号：US12981915

申请日：2010-12-30

Applicant: Ming-Der WU ,  Ming-Jen Cheng ,  Shie-Jea Lin ,  Chi-Hua Chen ,  Yen-Lin Chen ,  Hui-Ping Chen ,  Kai-Ping Chen ,  Ping-Shin Yang ,  Shiow-Wen Chen ,  Gwo-Fang Yuan

Inventor： Ming-Der WU ,  Ming-Jen Cheng ,  Shie-Jea Lin ,  Chi-Hua Chen ,  Yen-Lin Chen ,  Hui-Ping Chen ,  Kai-Ping Chen ,  Ping-Shin Yang ,  Shiow-Wen Chen ,  Gwo-Fang Yuan

IPC: A61K36/062 ,  C07D213/80 ,  A61K31/44 ,  A61P3/04 ,  A61P3/10 ,  A61P9/00 ,  C12P17/12

CPC classification number: A61K36/062 ,  A61K31/44 ,  A61K45/06 ,  C07D213/80 ,  C12P17/12 ,  C12R1/645 ,  A61K2300/00

Abstract: The present invention relates to novel pyridine alkaloid compounds of formula (I): or a pharmaceutically acceptable derivative thereof as described in the specification, the process for the preparation of the same, and the composition comprising the same. The uses of a pyridine compound for increasing the activity of PPARγ, for the prevention and/or treatment of a disease or disorder related to insulin resistance, and for the prevention and/or treatment of metabolic syndrome or its complication are also provided. The invention also provides extracts of red yeast-fermented products and their uses for prevention and/or treatment of a disease or disorder related to insulin resistance, such as metabolic syndrome.

Abstract translation: 本发明涉及式（I）的新型吡啶类生物碱化合物或其说明书所述的药学上可接受的衍生物，其制备方法及其组合物。 还提供了吡啶化合物用于增加PPARγ的活性，用于预防和/或治疗与胰岛素抵抗有关的疾病或病症以及预防和/或治疗代谢综合征或其并发症的用途。 本发明还提供红酵母发酵产物的提取物及其用于预防和/或治疗与胰岛素抵抗相关的疾病或病症如代谢综合征的用途。

公开(公告)号：US20100256227A1

公开(公告)日：2010-10-07

申请号：US12753918

申请日：2010-04-05

Applicant: Ta-Wei D. LIU ,  Yen-Lin Chen ,  Ming-Der Wu ,  Ming-Jen Cheng ,  Hui-Ping Chen ,  Wen-Jung Wu ,  Kai-Ping Chen ,  Yu-Shan Lin ,  Gwo-Fang Yuan

Inventor： Ta-Wei D. LIU ,  Yen-Lin Chen ,  Ming-Der Wu ,  Ming-Jen Cheng ,  Hui-Ping Chen ,  Wen-Jung Wu ,  Kai-Ping Chen ,  Yu-Shan Lin ,  Gwo-Fang Yuan

IPC: A61K31/365 ,  A61P35/00 ,  A61P5/00 ,  A61P17/10

CPC classification number: A61K31/365

Abstract: The present invention concerns the uses of an azaphilone compound of formula (I):formula (I): or a pharmaceutically acceptable derivative thereof as described in the specification for modulation of the activity of a nuclear hormone receptor and for prevention and/or treatment of a disease or disorder related to nuclear hormone receptor activity.

Abstract translation: 本发明涉及式（I）的阿扎伐隆化合物：式（I）：或其药学上可接受的衍生物在本说明书中所述的用于调节核激素受体的活性和用于预防和/或治疗 与核激素受体活性有关的疾病或病症。

公开(公告)号：US07779539B2

公开(公告)日：2010-08-24

申请号：US11637788

申请日：2006-12-13

Applicant: Hui-Ping Chen ,  Chien-Chung Chen ,  Yu-Ching Chen

Inventor： Hui-Ping Chen ,  Chien-Chung Chen ,  Yu-Ching Chen

IPC: H05K3/02

CPC classification number: H05K1/118 ,  H05K3/0058 ,  H05K3/281 ,  H05K2201/2009 ,  H05K2203/0191 ,  H05K2203/0264 ,  H05K2203/162 ,  Y10T29/49155 ,  Y10T29/49156 ,  Y10T29/49158 ,  Y10T29/49732

Abstract: A method for preventing broken circuits of an FPC is provided, which is to attach a film to a surface of the FPC so as to enhance the strength of the FPC.

Abstract translation: 提供了一种防止FPC断路的方法，其将FPC附着到FPC的表面以提高FPC的强度。